Product Information

BACLOFEN 20 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0569 per EA under NDC 59651039501. Its NADAC has been published 244 times since Mar 23, 2022.

FDA first approved this application on Jul 13, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BACLOFEN 20 MG TABLET

BACLOFEN
$0.0569per EA

Strength

20 mg/1

NDC

59651039501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

BACLOFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA214099

FDA Approved

7/13/2021

TE Code

AB

On Market Since

7/13/2021

Pharmacological Classes

GABA A Agonists
GABA B Agonists
gamma-Aminobutyric Acid-ergic Agonist

Price Statistics

The NADAC for BACLOFEN 20 MG TABLET has been published 244 times since Mar 23, 2022, and over the history we have for it it has declined 53.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0569 per EA
All-time high$0.1229 (Apr 13, 2022)
All-time low$0.0463 (Nov 20, 2024)
52-week high$0.0569
52-week low$0.0509
Median price$0.0606
Average price$0.0711
Largest weekly change+29.3% (Aug 21, 2024)
Weeks tracked244
Tracking sinceMar 23, 2022

Price History

1W

+4.4%

1M

+9.8%

3M

+11.9%

6M

+2.4%

1Y

+6.1%

3Y

-22.1%

5Y

N/A

All

-53.7%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BACLOFEN 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BACLOFEN 20 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0569 per EA (NDC 59651039501), effective Nov 18, 2026.

How has the price of BACLOFEN 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for BACLOFEN 20 MG TABLET has declined 53.7%. It has been tracked across 244 weekly CMS publications since Mar 23, 2022.

What are the highest and lowest recorded NADAC prices for BACLOFEN 20 MG TABLET?

Since Mar 23, 2022, the NADAC for BACLOFEN 20 MG TABLET has ranged from a low of $0.0463 (Nov 20, 2024) to a high of $0.1229 (Apr 13, 2022), with a median of $0.0606 per EA.

Are there cheaper alternatives to BACLOFEN 20 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BACLOFEN 20 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BACLOFEN 20 MG TABLET?

BACLOFEN 20 MG TABLET (NDC 59651039501) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.